April 28th 2025
A new study reveals ongoing burden of moderate to severe atopic dermatitis in youth, with flares, comorbidities, and quality of life impacts.
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Revolutionizing Atopic Dermatitis (RAD) Conference 2025
June 6-7, 2025
Register Now!
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
July 26, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
Add some acupuncture to your practice
June 1st 2005National report — When traditional approaches fail, many skin conditions may benefit from the addition of a few needles — acupuncture needles, that is. Some physicians are having good success integrating acupuncture into their dermatological practices.
Vitamin D deficiency unlikely, study says
June 1st 2005National report — Results of a study assessing sunlight exposure during winter months in various geographic locations across the United States refute the idea that "safe sun" photoprotection practices are associated with a risk of vitamin D deficiency, says J. Frank Nash, Ph.D., principle scientist, Procter & Gamble Co., Cincinnati.
Medicare woes add to practice difficulties
June 1st 2005Should the cuts take place as planned, 18 percent of physicians surveyed by the American Medical Association say they would stop accepting new Medicare patients; 57 percent would decrease time spent with patients; and 46 percent would reduce staffing levels.
Pilot trial: NB-UVB not enhanced by tacrolimus
May 1st 2005New Orleans — Concomitant topical treatment with tacrolimus 0.1 percent ointment (Protopic, Fujisawa) does not improve the response of generalized vitiligo to narrowband UVB phototherapy, according to the results of a randomized, double-blind, placebo-controlled, pilot study undertaken by researchers at the University of Texas Southwestern Medical Center.
Tacrolimus, UVB therapy synergistic duo
May 1st 2005Nice, France — Results of a comparative, prospective, randomized study undertaken by French dermatologists indicate that topical tacrolimus ointment 0.1 percent (Protopic, Fujisawa) plus phototherapy with a 308-nm excimer laser can be a highly effective combination for the treatment of recalcitrant, localized vitiligo.
West Nile virus skin symptoms documented
May 1st 2005New Orleans — Scientific literature rarely portrays cutaneous manifestations of West Nile virus (WNV) because these manifestations are, by nature, transient. However, a recent case report contains what is only the second publication of these symptoms.
Overuse of black box warnings is scare tactic
May 1st 2005As the Vioxx/Celebrex scandal lays waste to the American healthcare landscape as we know it, the U.S. Food and Drug Administration (FDA) finds itself under relentless pressure to get things right. Congress is demanding more stringent safety standards and even threatening to create a new federal agency to take safety approvals and monitoring out of the FDA's hands.
Candida antifungal performs well in study
April 1st 2005An investigational topical antifungal product containing miconazole nitrate 0.25 percent in a petrolatum/zinc oxide barrier ointment base (Zimycan, Barrier Therapeutics) has demonstrated positive efficacy and safety results in a phase 3 study of the treatment of Candida diaper dermatitis.
Testing identifies key culprits in ACD
April 1st 2005Miami — Bacitracin has been labeled a top cause of allergic contact dermatitis (ACD) in children. Notably, it is an ingredient in Neosporin (Pfizer) and a staple in first aid kits in schools, summer camps and just about every other child-centered environment. Yet private practitioners do not routinely test for this allergen.
Mastocytosis: Be alert to vague symptoms
April 1st 2005Loma Linda, Calif. — Dermatologists don't discuss mastocytosis much because it is rare and confusing, but, in large metropolitan areas, the incidence rate can add up to many patients, says Linda Golkar, M.D., assistant professor of dermatology, Loma Linda University, Loma Linda, Calif. Learning when to consider the disease, what diagnostic tests to perform and how to exclude involvement of other organs are required skills for front-line treatment.
Superficial peds infections abound
April 1st 2005New Orleans - In today's global, transient and sometimes overcrowded society, the spread of superficial cutaneous infections and infestations in children appears to be even more common than previously thought. International travel, immigration and foreign adoption have altered the typical distribution of some pediatric infections and infestations.
Advances aid treatment in pediatric dermatology
April 1st 2005There have been a number of important advances in pediatric dermatology, ranging from finding the optimal use for tissue adhesives to gaining a better understanding of general and local anesthetic use in the pediatric population and a greater appreciation for dermatologic surgeons' roles in treating vascular lesions and birthmarks.